DELLA TORRE, EMANUEL
 Distribuzione geografica
Continente #
EU - Europa 1.053
NA - Nord America 692
AS - Asia 233
OC - Oceania 11
AF - Africa 5
SA - Sud America 3
Totale 1.997
Nazione #
US - Stati Uniti d'America 683
IT - Italia 453
SE - Svezia 443
CN - Cina 139
FI - Finlandia 67
SG - Singapore 45
DE - Germania 21
GB - Regno Unito 21
HK - Hong Kong 14
IE - Irlanda 13
ES - Italia 10
IN - India 10
CA - Canada 7
NZ - Nuova Zelanda 7
CH - Svizzera 6
NL - Olanda 5
PK - Pakistan 5
AU - Australia 4
JP - Giappone 4
PH - Filippine 4
BR - Brasile 3
FR - Francia 3
IL - Israele 3
RU - Federazione Russa 3
UA - Ucraina 3
ZA - Sudafrica 3
AL - Albania 2
GR - Grecia 2
MA - Marocco 2
MX - Messico 2
MY - Malesia 2
SA - Arabia Saudita 2
TR - Turchia 2
TW - Taiwan 2
KR - Corea 1
RO - Romania 1
Totale 1.997
Città #
Lawrence 168
Princeton 168
New York 110
Shanghai 103
Milan 67
Helsinki 66
Boardman 34
Ashburn 30
Rome 29
Singapore 24
Turin 17
Seattle 16
Cagliari 13
Dublin 12
Mapello 12
Hong Kong 11
Pavia 10
Rovigo 10
Galliate 9
Bari 8
Pescara 8
Sundbyberg 8
Vaprio d'Adda 8
Verona 8
Alessandria 7
Calasparra 7
London 7
Naples 7
Borås 6
Auckland 5
Bergamo 5
Florence 5
Genoa 5
Mezzolombardo 5
Mira 5
Leeds 4
Los Angeles 4
Lucerne 4
Mantova 4
Minerbio 4
Nellore 4
Pune 4
Quezon City 4
Sesto San Giovanni 4
Thetford 4
Trino 4
Ancona 3
Castronno 3
Durban 3
East Providence 3
Kyiv 3
Piana degli Albanesi 3
Salt Lake City 3
San Lazzaro di Savena 3
Toronto 3
Vimercate 3
Vittoria 3
Al Qatif 2
Amsterdam 2
Andover 2
Athens 2
Atlanta 2
Bacoli 2
Benken 2
Biassono 2
Bologna 2
Boston 2
Brescia 2
Calci 2
Campobasso 2
Casablanca 2
Casoria 2
Castel Madama 2
Cosenza 2
Feilding 2
Foligno 2
Frankfurt am Main 2
Genova 2
Islamabad 2
Istanbul 2
La Spezia 2
Legnano 2
Lenta 2
Livorno 2
Meda 2
Melbourne 2
Messina 2
Mozzo 2
Ottawa 2
Parabiago 2
Pedrengo 2
Pisa 2
Portogruaro 2
Ravenna 2
Reggio Emilia 2
Rimini 2
Rio de Janeiro 2
Rozzano 2
Sayula 2
Secaucus 2
Totale 1.176
Nome #
PACHIMENINGITE IPERTROFICA IGG4-CORRELATA: DIAGNOSI E RISPOSTA TERAPEUTICA 181
Outcomes of non-invasive ventilation as the ceiling of treatment in patients with COVID-19 44
Dupilumab as a potential steroid-sparing treatment for IgG4-related disease. 39
Efficacy of a rational algorithm to assess allergy risk in patients receiving the BNT162b2 vaccine 39
Analisi delle sottopopolazioni T linfocitarie su sangue periferico dei pazienti affetti da malattia IgG4 correlata: aspetti patogenetici e risposta alla terapia con rituximab 37
IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients 32
A subset of CD4+CD8α- Cytotoxic T cells is expanded in patients with IgG4-Related type 1 autoimmune pancreatitis and decreases with glucocorticoid treatment 30
Salivary Gland Disease in IgG4-Related Disease is Associated with Allergic Conditions 29
IMMUNOTERAPIA SPECIFICA E MALATTIA IgG4-CORRELATA: STUDIO EPIDEMIOLOGICO DI UN CENTRO DI RIFERIMENTO ITALIANO 29
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 27
La misurazione quantitativa dell’uptake di 18F-FDG in TC/PET riflette l’espansione dei plasmablasti circolanti nella malattia IgG4 correlata 27
Efficacy and safety of rituximab biosimilar (CT-P10) in IgG4-related disease: an observational prospective open-label cohort study 23
Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study 23
A cd8 alpha-negative subset of cd4+slamf7+ cytotoxic t cells is expanded in patients with igg4-related disease and decreases following glucocorticoid treatment 23
Systemic lupus erythematosus and COVID-19: what we know so far 21
A CD8α− Subset of CD4+SLAMF7+ Cytotoxic T Cells Is Expanded in Patients With IgG4-Related Disease and Decreases Following Glucocorticoid Treatment 20
B lymphocytes directly contribute to tissue fibrosis in IgG4-Related Disease 20
A unique case of IgG4-related pachymeningitis treated with intrathecal rituximab 20
B lymphocytes directly contribute to tissue fibrosis in IgG4-Related Disease 20
Malattia sistemica e colangiopatia IgG4-relata 20
Cannabaceae pollen in the atmosphere of Brianza, Northen Italy 20
Methotrexate as induction of remission therapy for localized manifestations of IgG4-Related Disease. 19
B LYMPHOCYTES DIRECTLY CONTRIBUTE TO TISSUE FIBROSIS IN IGG4-RELATED DISEASE 19
IgG4-Related Midline Destructive Lesion: Expanding the spectrum of organ involvement in IgG4-related disease 19
B LYMPHOCYTES DIRECTLY CONTRIBUTE TO TISSUE FIBROSIS IN IGG4-RELATED DISEASE 18
EFFETTI DEL PREDNISONE SULLE SOTTOPOPOLAZIONI B LINFOCITARIE NEI PAZIENTI CON MALATTIA IgG4-CORRELATA 18
IDENTIFICAZIONE DI UNA SOTTOPOPOLAZIONE CD8- DI LINFOCITI CD4 CITOTOSSICI ESPANSA NEI PAZIENTI CON MALATTIA IGG4-CORRELATA E RESPONSIVA ALLA TERAPIA CON GLUCOCORTICOIDI 18
B lymphocytes directly contribute to tissue fibrosis in patients with IgG4-related disease. 18
Advances in the diagnosis and management of IgG4 related disease. 18
Nailfold capillaroscopy findings in patients with coronavirus disease 2019: Broadening the spectrum of COVID-19 microvascular involvement. 18
Deconstructing IgG4-related disease involvement of midline structures: Comparison to common mimickers. 17
Side effects from polydioxanone 17
B cells orchestrate tissue fibrosis in IgG4-Related Disease 17
IgG4-related pachymeningitis: evidence of intrathecal IgG4 on cerebrospinal fluid analysis. 16
Clonal Expansion of a Speci c Subset of Cytotoxic CD4+T Cells and Tissue Apoptosis in Patients with IgG4-related Disease 16
"How I manage" IgG4-Related Disease 16
B LYMPHOCYTES DIRECTLY CONTRIBUTE TO TISSUE FIBROSIS IN IGG4-RELATED AUTOIMMUNE PANCREATITIS 16
CLINICAL PHENOTYPES OF IGG4- RELATED DISEASE REFLECT DIFFERENCES IN EPIDEMIOLOGICAL FEATURES, SEROLOGICAL FINDINGS,AND PROGNOSTIC OUTCOMES 16
Antineutrophil cytoplasmic antibody positivity in IgG4-related disease: A case report and review of the literature. 15
ASSOCIAZIONE TRA MALATTIA IGG4-CORRELATA E IMMUNOTERAPIA ALLERGENE-SPECIFICA. STUDIO EPIDEMIOLOGICO DI UN CENTRO DI RIFERIMENTO ITALIANO. 15
METHOTREXATE PER IL MANTENIMENTO DELLA REMISSIONE INDOTTA DA STEROIDI NELLA MALATTIA IgG4-CORRELATA 15
European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendations. 15
B-cell depletion attenuates serological biomarkers of fibrosis and myofibroblast activation in IgG4-related disease. 15
ANTIAPOPTOTIC AND IMMUNOMODULATORY EFFECTS OF INTERLEUKIN 7 IN AN EX VIVO MODEL OF HUMAN LYMPHOID TISSUE 14
INCREASE OF CIRCULATING MEMORY B CELLS AFTER GLUCOCORTICOID-INDUCED REMISSION PREDICTS IGG4-RELATED DISEASE RELAPSE 14
HYPERSENSITIVITY REACTIONS TO LOW MOLECULAR WEIGHT HEPARIN IN A PREGNANT WOMAN 14
Sindrome da Iper IgG4: update e terapia 14
Incidence of endocrine and exocrine insufficiency in patients with autoimmune pancreatitis at diagnosis and after treatment: a systematic review and meta-analysis 13
Cerebrospinal fluid analysis in immunoglobulin G4-related hypertrophic pachymeningitis 13
ALLERGIC PROFILE AND ALLERGENSPECIFIC IMMUNOTHERAPY IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA): A SINGLE CENTER OBSERVATIONAL STUDY 13
IGG4 RELATED HYPERTROPHIC PACHYMENINGITIS: DIAGNOSTIC APPROACH AND THERAPEUTIC OUTCOMES 13
LONG-TERM EFFICACY OF RITUXIMAB MAINTENANCE THERAPY FOR IGG4- RELATED DISEASE RITUXIMAB MAINTENANCE THERAPY IN IGG4-RELATED DISEASE 13
INFLAMMATORY ACTIVITY OF IgG4-RELATED DISEASE LESIONS ASSESSED BY QUANTITATIVE POSITRON EMISSION TOMOGRAPHY CORRELATES WITH CIRCULATING PLASMABLASTS LEVELS 13
METHOTREXATE AS INDUCTION OF REMISSION THERAPY FOR LOCALIZED MANIFESTATIONS OF IGG4-RELATED DISEASE 13
IGG4 RELATED HYPERTROPHIC PACHYMENINGITIS: DIAGNOSTIC APPROACH AND THERAPEUTIC OUTCOMES 13
25. Epinephrine autoinjector prescription in food-allergic adults: symptom-based only or allergen-based also? An Italian multi-centre study. 13
Atopia e malattia IgG4-correlata: relazione casuale o causale? 13
EUS-guided ablation with the HybridTherm Probe as second-line treatment in patients with locally advanced pancreatic ductal adenocarcinoma: A case-control study 12
Palate perforation differentiates cocaine-induced midline destructive lesions from granulomatosis with polyangiitis 12
Intrathecal rituximab for IgG4-related hypertrophic pachymeningitis 12
Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation 12
Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circula-ting plasmablasts in IgG4-related type 1 au-toimmune pancreatitis and other organs 12
Artrite reumatoide. Dottore mi spieghi meglio 12
Iper IgG4 12
EpidemAAITO: features of food allergy in Italian adults attending allergy clinics: a multi-centre study 12
Optimal management of DRESS syndrome in course of infectious endocarditis. 12
Sildenafil in pulmonary hypertension 12
Are atopy and eosinophilic bronchial inflammation associated with relapsing forms of chronic rhinosinusitis with nasal polyps? 11
CLONAL EXPANSION OF CD4+ CYTOTOXIC T LYMPHOCYTES IN IGG4-RELATED DISEASE 11
MAVRILIMUMAB IMPROVES OUTCOMES IN SEVERE COVID-19 PNEUMONIA AND SYSTEMIC HYPERINFLAMMATION 11
EFFICACY AND SAFETY OF RITUXIMAB FOR INDUCTION OF REMISSION AND MAINTENANCE OF IGG4-RELATED DISEASE: EXPERIENCE FROM AN ITALIAN NATIONAL REFERRAL CENTRE 11
CLINICAL MANIFESTATIONS OF IGG4-RELATED DISEASE ONSET REQUIRE ADMISSION TO THE EMERGENCY DEPARTMENT IN THE MAJORITY OF CASES. EXPERIENCE FROM A SINGLE ITALIAN REFERRAL CENTRE 11
MALATTIA IGG4-CORRELATA: ESPERIENZA QUINQUENNALE MONOCENTRICA SU UNA CORTE ITALIANA DI 150 PAZIENTI (2013 - 2018) 11
Effects Of Glucocorticoids On B Cell Subpopulations In Patients With IgG4-Related type I autoimmune pancreatitis 11
IDENTIFICATION OF GALECTIN-3 AS AN AUTO-ANTIGEN IN IGG4-RELATED DISEASE USING MONOCLONAL ANTIBODIES FROM DOMINANTLY EXPANDED PATIENT-DERIVED PLASMABLASTS 11
EFFETTI DELLA TERAPIA CON PREDNISONE E METHOTREXATE SULLE SOTTOPOPOLAZIONI B LINFOCITARIE NEI PAZIENTI AFFETTI DA MALATTIA-IgG4 CORRELATA 11
Causes of food-induced anaphylaxis in Italian adults: a multi-centre study 11
In vivo tests with "Tahini" sauce: new allergenic source to evaluate IgE-mediated hypersensitivity to sesame. 11
Utility of the “2019 ACR/EULAR classification criteria” for the management of patients with IgG4-related disease 10
Correspondence on 'Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort' 10
CLINICAL PHENOTYPES OF IGG4-RELATED DISEASE REFLECT DIFFERENCES IN EPIDEMIOLOGICAL, IMMUNOLOGICAL AND PROGNOSTIC FEATURES 10
EFFECTS OF COMBINED THERAPY WITH PREDNISONE AND METHOTREXATE ON B CELL SUBPOPULATIONS IN PATIENTS WITH IGG4-RELATED DISEASE 10
Identification of Galectin-3 as an autoantigen in IgG4-Related Disease using monoclonal antibodies from dominantly expanded patient-derived plasmablasts 10
IgG4-related hypertrophic pachymeningitis: clinical features, diagnostic criteria, and treatment. 10
Diagnostic value of IgG4 Indices in IgG4-related hypertrophic pachymeningitis. 10
Malattia IgG4 correlata: una patologia fibro-infiammatoria emergente di interesse internistico 10
IgG4-Related diseases 10
Lifetime Allergy Symptoms in IgG4-Related Disease: A Case-Control Study. 10
De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease. 10
IL-1 and IL-6 inhibition affects the neutralising activity of anti-SARS-CoV-2 antibodies in patients with COVID-19 10
Clinical features and outcomes of COVID-19 in patients with IgG4-related disease: A European multi-centre study 9
Methotrexate as Induction of Remission Therapy for Type 1 Autoimmune Pancreatitis 9
Juxta-vertebral lesions in granulomatosis with polyangiitis 9
Clonally Expanded CD4+ Cytotoxic T Cells, Endothelial Cell Apoptosis and the Pathogenesis of Early Systemic Sclerosis 9
CIRCULATING PLASMABLASTS LEVELS REFLECT INFLAMMATORY ACTIVITY IN IGG4-RELATED DISEASE LESIONS AS ASSESSED BY QUANTITATIVE POSITRON EMISSION TOMOGRAPHY 9
MERTK AND THE RESOLUTION OF INFLAMMATION IN IGG4-RELATED DISEASE 9
PROFILO ALLERGICO E IMMUNOTERAPIA SPECIFICA NELLA GRANULOMATOSI EOSINOFILA CON POLIANGIOITE: STUDIO OSSERVAZIONALE MONOCENTRICO 9
La gestione territoriale del paziente COVID-19 pre e post ricovero 9
An International, Multi-Specialty Validation Study of the IgG4-Related Disease Responder Index 9
Iper IgG4 9
Totale 1.732
Categoria #
all - tutte 31.239
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.239


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203 1 0 0 0 0 0 2 0 0 0 0 0
2020/20219 1 0 0 2 0 1 1 1 0 1 1 1
2021/2022307 0 0 146 28 6 16 12 21 28 15 18 17
2022/20231.026 420 189 59 8 31 103 55 44 57 13 21 26
2023/2024829 26 55 72 74 42 144 38 82 5 42 87 162
2024/202513 13 0 0 0 0 0 0 0 0 0 0 0
Totale 2.194